Get started
Author

Aditi Singh

Observed name: A. Singh
Observed institutions: Ascension, Mayo Clinic, St. John Medical Center, St. John Hospital & Medical Center, Mayo Clinic Comprehensive Cancer Center (Minnesota), UConn Health
ORCID: 0000-0002-9937-7048
Observed ORCID: 0000-0002-9937-7048
OpenAlex ID: A5012424924
Bronchorrhea, a Rare and Debilitating Symptom of Lung Cancer: Case Report and Review of the Treatment
2022 · Milind Bhagat, Aditi Singh, et al. · JTO Clinical and Research Reports · 5
Prevalence of Iron Deficiency in Endurance Runners: A Cross-Sectional Study of the Detroit Free Press Marathon and Half-Marathon Athletes
2022 · Laura Kohler, Zachary Pounders, et al. · Blood · 3
Choroidal effusion: a rare and unusual complication of daratumumab
2022 · Aditi Singh, Talal Bazzi, et al. · BMJ Case Reports · 3
Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report
2025 · Aditi Singh, Arthi Sridhar, et al. · JTO Clinical and Research Reports · 2
PDF
A Prospective Study Evaluating the Serological Profile of the Novel Coronavirus (COVID-19) Vaccines in Cancer Patients
2022 · Aditi Singh, Hemang Patel, et al. · Blood
Complement-Mediated Hemolytic Uremic Syndrome Presenting With Nephrotic Range Proteinuria
2022 · Aditi Singh, Stephen N. Simeone, et al. · Journal of the American Society of Nephrology
The Great Clinical Masquerade of ANCA Vasculitis
2022 · Aditi Singh, Stephen N. Simeone, et al. · Journal of the American Society of Nephrology
A Case of Metastatic Lung Squamous Cell Carcinoma with EGFR Mutation and Excellent Response to Osimertinib
2022 · H.K. Gharib, A. Singh, et al.
Works count: 8
Citation count: 13
H-index: 3
I10-index:
Year
Topic
Type